CAMP4 THERAPEUTICS Valuation
| CAMP Stock | USD 1.59 0.07 4.22% |
Based on Macroaxis valuation methodology, the entity appears to be undervalued. CAMP4 THERAPEUTICS shows a prevailing Real Value of $6.13 per share. The current price of the entity is $1.59. Our model approximates the value of CAMP4 THERAPEUTICS from examining the entity fundamentals such as Shares Owned By Institutions of 56.95 %, price to earning of 318.57 X, and Shares Owned By Insiders of 35.40 % as well as evaluating its technical indicators and probability of bankruptcy. Key fundamental drivers impacting CAMP4 THERAPEUTICS's valuation include:
Undervalued
Today
Please note that CAMP4 THERAPEUTICS's price fluctuation is relatively risky at this time. Calculation of the real value of CAMP4 THERAPEUTICS is based on 3 months time horizon. Increasing CAMP4 THERAPEUTICS's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
CAMP4 THERAPEUTICS's intrinsic value may or may not be the same as its current market price of 1.59, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.59 | Real 6.13 | Target 19.91 | Hype 1.56 | Naive 1.56 |
The intrinsic value of CAMP4 THERAPEUTICS's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence CAMP4 THERAPEUTICS's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of CAMP4 THERAPEUTICS PORATION helps investors to forecast how CAMP4 stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CAMP4 THERAPEUTICS more accurately as focusing exclusively on CAMP4 THERAPEUTICS's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use CAMP4 THERAPEUTICS's intrinsic value based on its ongoing forecasts of CAMP4 THERAPEUTICS's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against CAMP4 THERAPEUTICS's closest peers.
CAMP4 THERAPEUTICS Cash |
|
CAMP4 Valuation Trend
CAMP4 THERAPEUTICS's real value is important for investors to make better decisions and a more accurate overall view of CAMP4 THERAPEUTICS's financial worth over time. Using both CAMP4 THERAPEUTICS's enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
CAMP4 THERAPEUTICS Total Value Analysis
CAMP4 THERAPEUTICS PORATION is currently expected to have valuation of 109.74 M with market capitalization of 102.82 M, debt of 8.65 M, and cash on hands of 47.72 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the CAMP4 THERAPEUTICS fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
109.74 M | 102.82 M | 8.65 M | 47.72 M |
CAMP4 THERAPEUTICS Investor Information
About 35.0% of the company shares are held by company insiders. The company has Price/Earnings To Growth (PEG) ratio of 0.08. CAMP4 THERAPEUTICS recorded a loss per share of 2.64. The entity had not issued any dividends in recent years. The firm had 1:23 split on the 2nd of February 2024. Based on the key indicators related to CAMP4 THERAPEUTICS's liquidity, profitability, solvency, and operating efficiency, CAMP4 THERAPEUTICS PORATION may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter.CAMP4 THERAPEUTICS Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of CAMP4 connotes not a very effective usage of assets in July.CAMP4 THERAPEUTICS Ownership Allocation
CAMP4 THERAPEUTICS holds a total of 20.16 Million outstanding shares. Over half of CAMP4 THERAPEUTICS's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the entity is less than the current market value, you may not be able to make money on it.CAMP4 THERAPEUTICS Profitability Analysis
The company reported the previous year's revenue of 652 K. Net Loss for the year was (51.79 M) with loss before overhead, payroll, taxes, and interest of (37.93 M).About CAMP4 THERAPEUTICS Valuation
The stock valuation mechanism determines CAMP4 THERAPEUTICS's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of CAMP4 THERAPEUTICS based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of CAMP4 THERAPEUTICS. We calculate exposure to CAMP4 THERAPEUTICS's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CAMP4 THERAPEUTICS's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 652 K | 619.4 K | |
| Pretax Profit Margin | (79.43) | (75.46) | |
| Operating Profit Margin | (81.42) | (77.35) | |
| Net Loss | (79.43) | (75.46) | |
| Gross Profit Margin | 0.32 | 0.25 |
CAMP4 THERAPEUTICS Growth Indicators
Investing in growth stocks can be very risky. If the company such as CAMP4 THERAPEUTICS does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 19.5 M |
CAMP4 THERAPEUTICS Current Valuation Indicators
CAMP4 THERAPEUTICS's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final CAMP4 THERAPEUTICS's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as CAMP4 THERAPEUTICS, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use CAMP4 THERAPEUTICS's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes CAMP4 THERAPEUTICS's worth.Additional Tools for CAMP4 Stock Analysis
When running CAMP4 THERAPEUTICS's price analysis, check to measure CAMP4 THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CAMP4 THERAPEUTICS is operating at the current time. Most of CAMP4 THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of CAMP4 THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CAMP4 THERAPEUTICS's price. Additionally, you may evaluate how the addition of CAMP4 THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.